The use of nitroflavanoids for the treatment of anxiety

Author：  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.7, Iss.12, 1997-12, pp. : 1489-1491

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The use of nitroflavanoids for the treatment of anxiety

By Strathclyde WO9714414 U.o.  

Expert Opinion on Investigational Drugs, Vol. 7, Iss. 12, 1998-12 ,pp. : 1489-1492

Informa Healthcare

Access to resources Recommend Favorite

Duloxetine: A Review of its Use in the Treatment of Generalized Anxiety Disorder

By Carter Natalie J.   McCormack Paul L.  

CNS Drugs, Vol. 23, Iss. 6, 2009-05 ,pp. : 523-541

Adis International

Access to resources Recommend Favorite

The treatment of anxiety disorders in the elderly

By Sheehan D.V.   Ray B.A.   Sheehan K.H.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 248-249

Elsevier

Access to resources Recommend Favorite

Issues in the treatment of anxiety disorders

By  

Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Anxiety and Mood Disorders and Cannabis Use

By Cheung Joyce T. W.   Mann Robert E.   Ialomiteanu Anca   Stoduto Gina   Chan Vincy   Ala-Leppilampi Kari   Rehm Jürgen  

The American Journal of Drug and Alcohol Abuse, Vol. 36, Iss. 2, 2010-03 ,pp. : 118-122

Informa Healthcare

Access to resources Recommend Favorite